DSM Buys Biotech Firm

DSM says it has agreed to acquire privately held biotechnology company Biopract (Berlin). Financial details of the deal were not disclosed. The acquisition of Biopract will serve as an entry point for DSM into the biogas market, which is growing at 15%-20%/year, DSM says. Biopract focuses mainly on the commercialization and extension of its enzyme series for the improvement of agricultural and industrial biogas...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers